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Objective: To observe the effect of the cyclophosphamide (CTX) on systemic lupus
erythematosus mice by ﬂuorescent quantitative polymerase chain reaction.
Methods: (BALB/c × C57BL/J6) F1 hybrid mice were used as recipients of donor
lymphocytes which were injected intravenously. Mice were randomly divided into con-
trol group and treatment group, serum autoantibody and urinary protein were measured,
renal pathological changes and the situation of fungal infection were observed.
Results: The reduced urinary protein, ameliorated renal lesions were found in the CTX-
treated mice. Candida albicans and Aspergillus ﬂavus were detected respectively in
respiratory tract and gastrointestinal tract.
Conclusions: CTX can alleviate lupus nephritis and the ﬂuorescent quantitative PCR is a
rapid and sensitive method for the detection of fungal infection.1. Introduction
The systemic lupus erythematosus (SLE) is an autoim-
mune disease that is mediated by autoimmune and is char-
acterized by the multi-system lesions [1]. Its pathogenesis has
not been clear. To further explore its pathogenesis, the
appropriate animal model will be required. In this study,
relying on the recognized induced SLE mouse model [2],
we observed serum autoantibody, urinary protein and renal
pathological changes [2–4] and determine the effect of
cyclophosphamide. In addition, the ﬂuorescent quantitative
PCR [5] method was used for the detection of fungal
infection of SLE model mice.2. Materials and methods
2.1. Materials
Female BALB/c mice aged 6–8 wk and male C57BL/J6 mice
aged 6–8 wk were purchased from Laboratory Animal Center of
Chinese Academy of Sciences; the anti-dsDNA from Beijing
H&J NovoMed Co., Ltd, goat anti mouse FITC-IgG from Sigma
and DNA extraction kit and Fluorescent Quantitative PCR kit
from Takara Bio. The primer probe was synthesized by
Shanghai Invitrogen Biotechnology Co., Ltd.
2.2. Methods
2.2.1. Grouping of laboratory animals
The (female BALB/c × male C57BL/J6) F1 hybrid mice
(BCF1) were chosen as the research subjects. Female BCF1
mice were in the weight of (18 ± 4) g. A total of 72 mice were
randomly chosen for SLE induction. Another 24 mice were
selected as the normal control group.
2.2.2. Induction of SLE mouse model
The lymph node, thymus and spleen of BALB/c mice were
separated under sterile conditions, with the proportion of 1:2:3.pen access article under the CC BY-NC-ND
Table 1
Change in level of anti-dsDNA antibody in the SLE mice at different
weeks.
Group 12th week
(successful
modeling)
18th week
(6 wk of CTX
treatment)
24th week
(12 wk of CTX
treatment)
Normal control
group
– – –
Model group 11.13 ± 3.95 13.25 ± 2.11 14.15 ± 3.42
CTX administration
group
10.98 ± 2.56 8.44 ± 2.01 5.24 ± 1.11
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200 mm and 80 mm nylon sieve. The survival of lymphocytes was
observed and the number of cells was counted under the micro-
scope. The 50 × 106 living lymphocytes were injected into each
female BCF1 mouse through the tail vein every time. The injec-
tion time was at 0, 3, 7 and 10 h. Mice in the normal control group
were given the injection of normal saline by the equal volume.
2.2.3. Cyclophosphamide (CTX) treatment
A total of 12 wk after the modeling, 36 mice were randomly
selected as the CTX administration group. The intragastrical
administration was given every other day, lasting for 12 wk. The
administration dose was calculated according to the following
equation [6]: dB = dA × RB/RA × (WA/WB)
1/3, where, dB, dA are
the administration dose per kilogram for animals of B and A; RB,
RA are the body mass indices for these two animals respectively,
Rmouse = 90, Rhuman = 100; WA, WB are the weight (kg) for them
respectively. In addition, other 36 modeled mice were selected as
the model group. Mice in the normal control group and model
group were injected with the normal saline by the equal volume.
2.3. Sampling and detection
2.3.1. Analysis of anti-dsDNA antibody in serum of mice
The intravenous blood sampling was performed from the eye
orbit of mice in the normal control group, model group and CTX
administration group at 12th week (successful modeling), 18th
week (6 wk of CTX treatment) and 24th week (12 wk of CTX
treatment). The indirect immunoﬂuorescent assay was employed
to detect the autoantibody dsDNA.
2.3.2. Detection of severity of proteinuria in mice
The urine were collected using the reﬂex urination method
from mice in the normal control group, model group and CTX
administration group at 12th week (successful modeling), 18th
week (6 wk of CTX treatment) and 24th week (12 wk of CTX
treatment) [6]. The coomassie blue staining was employed to
detect the concentration of urinary protein.
2.3.3. Pathological section staining of mouse kidney
tissue
Six mice in the normal control group and model group were
executed at 12th week respectively; while remained ones in the
normal control group, model group and CTX administration
group were executed at 24th week. The kidney was collected for
the pathological section HE staining. The change in the histo-
morphology of kidney was analyzed under the optical micro-
scope [7].
2.3.4. Observation of immune complexes deposited in
kidney tissue of mouse
After the deparafﬁnage of above parafﬁn sections, the goat
anti mouse FITC-IgG was added for the incubation. After being
washed and mounted, they were observed under the ﬂuorescence
microscope for the deposition of immune complexes.
2.3.5. Ultrastructural changes of kidney tissue of mouse
The kidney tissue was ﬁxed with the glutaraldehyde solution.
After being dehydrated, primarily stained and counter stained,
the ultrastructure of kidney tissue was observed under the
transmission electron microscope.2.3.6. Detection of Candida albicans (C. albicans) and
Aspergillus ﬂavus (A. ﬂavus) by ﬂuorescent quantitative
PCR
Before the execution of mice at 24th week, the whole blood,
urine and excrement of mice were collected. Only the lungs were
collected from the executed mice. DNA of excrement, whole
blood, urine and lung tissue was extracted respectively and then
stored at −80 C.
The DNA gene sequence of C. albicans and A. ﬂavus could be
referred to NCBI website and then the PCR primers of C. albicans
and A. ﬂavus could be designed. The sequence for 2 pairs of primers
was: C. albicans: F 50-TCTCCCTCAAACCGCTGGG; R 50-
GGTTAGACCTAAGCCATTGTCAAAG; A. ﬂavus: F 50-
GCTGCCCATCAAGCACGG; R 50-CCTACAGAGCGGGTGA-
CAAAG. The 50 mL PCR reaction system contained 10 mL reaction
buffer, 1 mL Taq Mix, 1 mL dNTP, and 0.5 mL upstream primer,
downstream primer and probe of C. albicans and A. ﬂavus respec-
tively. Five mL extracted DNA was supplemented with water to
50 mL. Roche 480 PCR system was employed for the ampliﬁcation
reaction, with the reaction conditions as follows: 93 C for 3 min;
94 C for 45 s, 55 C for 1 min, with 4–5 repeats. The ﬂuorescence
signal was collected at 55 C.
2.4. Statistical analysis
All data was treated with SPSS13.0 for the statistical anal-
ysis, while P < 0.05 indicated the signiﬁcant difference.
3. Results
3.1. General conditions
Modeled mice showed the reduced activity, increased weight,
darkened hair and edema to different extents since the 4th week.
During the period from 18th week to 24th week, 2 mice in the
model group died. After the treatment, mice in CTX treatment
group had the gradually increased weight, good activity and
normal feeding. The conditions for mice in the normal control
group were good.
3.2. Change in level of anti-dsDNA antibody in serum of
mice
After the successful modeling, the titer of anti-dsDNA anti-
body was obviously increased in the model group and CTX
administration group. At different weeks, the titer of anti-
dsDNA antibody in the serum of mice that were treated with
CTX was signiﬁcantly lower than the one in the model group
(P < 0.05), as shown in Table 1.
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mice during 24 h
After the successful modeling, mice in the model group and
CTX administration group all had the proteinuria. At differentTable 2
Change in level of proteinuria in the SLE mice at different weeks (mg).
Group 12th week
(successful
modeling)
18th week
(6 wk of CTX
treatment)
24th week
(12 wk of CTX
treatment)
Normal control
group
– – –
Model group 5.68 ± 0.33 6.75 ± 0.45 7.22 ± 0.22
CTX administration
group
5.54 ± 0.56 2.84 ± 0.24 0.67 ± 0.11
Figure 1. Pathological change of kidney tissue of SLE mouse.
Figure 2. Deposition of immune complexes in kidney tissue.weeks, the level of proteinuria for mice in CTX treatment group
was signiﬁcantly decreased (P < 0.05), as shown in Table 2.
3.4. Pathological change of kidney tissue
The HE-stained kidney tissue of modeled mouse was
observed under the microscope. The volume compensation of
glomerulus was increased, as well as the number of glomus
cells. The inﬂammatory cell inﬁltration and hyperplasia of
endothelial cells and mesangial matrix in mice treated with CTX
were improved to the different extent (Figure 1).
3.5. Deposition of immune complexes in kidney tissue
The obvious granular ﬂuorescence could be found in the
glomerulus of SLE mice. The ﬂuorescence was deposited in the
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the different extent (Figure 2).
3.6. Ultrastructural change of kidney tissue
For the observation under the electron microscope, it could
be indicated that the hyperplasia of endothelial cells and
mesangial matrix in mice treated with CTX were improved to
the different extent (Figure 3).
3.7. Defection of C. albicans and A. ﬂavus
The ﬂuorescent quantitative PCR was employed to detect the
gene sequence of C. albicans and A. ﬂavus. In CTX treatment
group, the C. albicans was found in 2 mice and A. ﬂavus in 1
mouse, with the detection part of lung and gastrointestinal tract.
The detection rat was 6.52%. There was no fungus found in the
mice in normal control group and model group.Figure 3. Ultrastructural change of kidney tissue under electron microscope.4. Discussion
The systemic lupus erythematosus is the typical representa-
tive of autoimmune diseases. Its pathogenetic characteristic is
that T and B-lymphocytes are highly activated and the level of
multiple autoantibodies is extremely increased to form the highlevel of immune complexes and thus result in the injuries of
tissues and organs [8,9]. Its pathogenesis has not been fully
understood and the researches on such disease were mainly
based on the animal model. According to previous ﬁndings
[10,11], such model was related to the gender and it preferred
to the female mice. Accordingly, (BALB/c × C57BL/J6) F1
hybrid mice were selected for the modeling. Because of the
abundant source, such mouse is suitable for all kinds of
laboratory researches. The disease characteristic of such SLE
mouse model is the lymphoid hyperplasia to cause the
autoantibody similar with SLE patients and thus result in the
kidney diseases mediated by immune complexes.
Results of this study showed that, the expression of anti-
dsDNA antibody was positive in induced SLE mice that had
the proteinuria, which was consistent with the ﬁndings by the
foreign scholar [2]. Bruijn et al. [12] reported that, after 12–14 wk
of induction, the kidney of mice had the defused hyperplasia of
glomerulus and membranous glomerulonephritis, while the micewith severe condition had the ball-like glomerulosclerosis. Ac-
cording to our induced model, such lesion appeared at the 12th
week, mainly the abundant inﬂammatory cell inﬁltration and
hyperplasia of endothelial cells and mesangial matrix. After
being treated with the large dose of immunosuppressive agent,
the level of anti-dsDNA antibody and proteinuria in modeled
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logical change of kidney tissue had been signiﬁcantly improved.
According to the clinical researches in recent years, the inci-
dence of systemic lupus erythematosus combined with fungal
infection showed the increase trend and became one of important
death causes for patients with systemic lupus erythematosus [13].
The fungal infection was most common in the death because of a
single pathogen infection [14]. In this study, it was the ﬁrst time
that the ﬂuorescent quantitative PCR method was employed for
the ampliﬁcation of C. albicans and A. ﬂavus that were
commonly accompanied with the systemic lupus erythematosus.
Besides, the C. albicans and A. ﬂavus were found in the lung and
gastrointestinal tract of CTX-treated mice. It was similar with the
ﬁndings of Du [15] in the clinical practice that patients with
systemic lupus erythematosus usually had the invasive fungal
infection in the lung. It was also in accordance with the ﬁndings
of Deng [16] that the pathogen for patients with systemic lupus
erythematosus combined with invasive fungal infection was
mainly C. albicans. It should be specially emphasized that the
real-time ﬂuorescent quantitative PCR method has the good
sensitivity and speciﬁcity, which can overcome the disadvantages
of low culture sensitivity and long culture time of fungus and thus
serve as a rapid and correct method for fungus detection.
However, there are certain limitations in this study. Only the
most common C. albicans and A. ﬂavus were ampliﬁed in the
laboratory, without the detection on other funguses. With the
deeper understanding of systemic lupus erythematosus com-
bined with fungal infection, the further detection on other fun-
guses should be performed, which will lead to the better
understanding of the systemic lupus erythematosus.
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